Although a peanut allergy is commonly associated with pediatric care, a new study found that up to one in six adults with peanut sensitivity developed it after age 18. The report, presented by Northwestern University researchers in the Journal of Allergy and Clinical Immunology, found that 2.9% of American adults report a current allergy to peanuts, but only 1.8% report an allergy diagnosed by the doctor and / or history of reaction symptoms.

In addition, among this group, two out of three adults have at least one other food allergy, such as nuts or shellfish. The researchers say the lack of allergy diagnosed by the doctor is worrying, as this means that patients do not have a current epinephrine prescription, possibly leaving them susceptible to serious reactions without potentially saving treatment.

The researchers also noted that the only approved therapy for peanut allergy is aimed at pediatric patients under 17 years old.
(iStock)

The report, which is believed to be the first to provide an estimate of peanut allergy in adults, suggests that at least 4.5 million adults in the United States are affected by the allergy.

THE NEW JERSEY MAN’S DOUBLE-HAND TRANSPLANTATION IS THE FIRST SUCCESSFUL WORLD ATTEMPT

“Unlike allergies like milk or eggs, which often develop early in life and are overcome in adolescence, peanut allergy appears to affect children and adults to a similar degree,” Christopher Warren, director of population health at the Allergy Center Feinberg’s Food and Asthma The research and co-first author said, according to a press release published on Eurekalert.org. “Our study shows that many adults are not overcoming their childhood allergies to peanuts, and many adults are developing allergies to peanuts for the first time.”

The researchers also noted that the only approved therapy for peanut allergy is intended for pediatric patients under 17 years old and called for further research in adult patients and additional therapies.

THE RESEARCHER BEHIND THE COVID-19 SALIVA TEST DIES UNEXPECTED

“Given the high prevalence of peanut allergy among US adults, additional therapies are needed to help deal with this growing burden of the disease,” Dr. Ruchi Gupta, author of the study and professor of pediatrics at Northwestern Feinberg School of Medicine University and doctor at Ann & Robert H. Lurie Children’s Hospital in Chicago, said in the Eurekalert.org press release.

Although a peanut allergy is commonly associated with pediatric care, a new study found that up to one in six adults with peanut sensitivity developed it after age 18. The report, presented by Northwestern University researchers in the Journal of Allergy and Clinical Immunology, found that 2.9% of American adults report a current allergy to peanuts, but only 1.8% report an allergy diagnosed by the doctor and / or history of reaction symptoms.

In addition, among this group, two out of three adults have at least one other food allergy, such as nuts or shellfish. The researchers say the lack of allergy diagnosed by the doctor is worrying, as this means that patients do not have a current epinephrine prescription, possibly leaving them susceptible to serious reactions without potentially saving treatment.

The researchers also noted that the only approved therapy for peanut allergy is aimed at pediatric patients under 17 years old.
(iStock)

The report, which is believed to be the first to provide an estimate of peanut allergy in adults, suggests that at least 4.5 million adults in the United States are affected by the allergy.

THE NEW JERSEY MAN’S DOUBLE-HAND TRANSPLANTATION IS THE FIRST SUCCESSFUL WORLD ATTEMPT

“Unlike allergies like milk or eggs, which often develop early in life and are overcome in adolescence, peanut allergy appears to affect children and adults to a similar degree,” Christopher Warren, director of population health at the Allergy Center Feinberg’s Food and Asthma The research and co-first author said, according to a press release published on Eurekalert.org. “Our study shows that many adults are not overcoming their childhood allergies to peanuts, and many adults are developing allergies to peanuts for the first time.”

The researchers also noted that the only approved therapy for peanut allergy is aimed at pediatric patients under the age of 17 and called for more research on adult patients and additional therapies.

THE RESEARCHER BEHIND THE COVID-19 SALIVA TEST DIES UNEXPECTED

“Given the high prevalence of peanut allergy among US adults, additional therapies are needed to help deal with this growing burden of the disease,” Dr. Ruchi Gupta, author of the study and professor of pediatrics at Northwestern Feinberg School of Medicine University and physician at Ann & Robert H. Lurie Children’s Hospital in Chicago, said in the Eurekalert.org press release.